QT
CLLS

Quantamental Technologies’s Cellectis CLLS Stock Holding History

Quantamental Technologies’s Portfolio CLLS Stock Details CLLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-200
Closed -$2K – 582
2019
Q3 		$2K Buy
200
+52
+35% +$699 ﹤0.01% 1435
2019
Q2 		$2K Buy
148
+32
+28% +$571 ﹤0.01% 1375
2019
Q1 		$2K Buy
+116
New +$2.06K ﹤0.01% 1375

Other funds holding CLLS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Quantamental Technologies's CLLS Position: Q4 2019 in Review

Quantamental Technologies sold out of Cellectis (CLLS) in Q4 2019, closing a stake of 200 shares — an estimated $2K sold.

Quantamental Technologies first reported a position in CLLS in Q1 2019 and held it in 3 quarters. The position peaked at $2K in Q3 2019. 60 funds tracked by Wall St. Rank hold CLLS as of Q4 2019.

  • Quantamental Technologies reported no remaining Cellectis position as of Q4 2019 after selling out during the quarter.
  • Quantamental Technologies sold 200 Cellectis shares in Q4 2019, an estimated $2K.
  • Quantamental Technologies first reported a position in Cellectis in Q1 2019 and held it in 3 quarters.
  • Quantamental Technologies's Cellectis position peaked at $2K in Q3 2019.
  • 60 funds tracked by Wall St. Rank held Cellectis as of Q4 2019.

Based on Quantamental Technologies's 13F filing for Q4 2019, filed 14 Feb 2020.